Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07137130) titled 'Secretome TGF Beta 3' on Aug. 6.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Single (Investigator).

Primary Sponsor: Indonesia University

Condition: Melasma

Intervention: Drug: Concentrated secretome Injection 3 mL

Recruitment Status: Not recruiting

Phase: N/A

Date of First Enrollment: February 14, 2026

Target Sample Size: 34

Countries of Recruitment: Indonesia

To know more, visit https://clinicaltrials.gov/ct2/show/NCT07137130

Published by HT Digital Content Services with permission from Health Daily D...